Effects of CYP3A4, CYP3A5, and ABCB1 genetic variants on tacrolimus metabolism during the early period after kidney transplantation

PHARMACOGENOMICS JOURNAL · Published 2026-07-30 · DOI 10.1038/s41397-026-00427-z

Authors (7)

Nahathai Dukaew, Kajohnsak Noppakun, Mingkwan Na Takuathung, Nattharinee Kongta, Ratchanon Inpan, Naruemon Suyayai, Nut Koonrungsesomboon

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Dukaew, N., Noppakun, K., Takuathung, M., et al. (2026). Effects of CYP3A4, CYP3A5, and ABCB1 genetic variants on tacrolimus metabolism during the early period after kidney transplantation. PHARMACOGENOMICS JOURNAL. https://doi.org/10.1038/s41397-026-00427-z

Related articles

• Both donor and recipient CYP3A5 gene polymorphisms represent as significant factors influencing Tacrolimus weight-dose adjusted concentration in the early phase after living donor liver transplantation · Pharmaceutical Sciences Asia · 2024 · Cites or is cited by this article
• Cardiovascular prescriber attitudes to pharmacogenomics: a survey by the ESC working group on cardiovascular pharmacotherapy · PHARMACOGENOMICS JOURNAL · 2026 · Same journal
• Impact of low BMI and ABCC2 genotype on the clinical response of sequential anthracycline-taxane chemotherapy receiving breast cancer patients: a hospital-based study · PHARMACOGENOMICS JOURNAL · 2025 · Same journal
• Understanding public perspectives on direct-to-consumer pharmacogenomic testing in the UK: a qualitative study · PHARMACOGENOMICS JOURNAL · 2026 · Same journal
• A functional ancestry-linked regulatory haplotype influences CYP2D6 expression · PHARMACOGENOMICS JOURNAL · 2026 · Same journal
• Genetic markers of early response to lurasidone in acute schizophrenia · PHARMACOGENOMICS JOURNAL · 2025 · Same journal
• The association between the number of HLA risk alleles and drug allergy and its implications for HLA screening – a case-control study · PHARMACOGENOMICS JOURNAL · 2025 · Same journal
• Analyzing pharmacogenetics cost effectiveness and savings across common health conditions in the United States · PHARMACOGENOMICS JOURNAL · 2025 · Same journal
• Meta-analysis and review of in silico methods in drug discovery – part 1: technological evolution and trends from big data to chemical space · PHARMACOGENOMICS JOURNAL · 2025 · Same journal
• The association of ABCB1, CYP2C19 and CYP2C9 combined activity with clopidogrel resistance in patients with recurrent ischemic stroke · PHARMACOGENOMICS JOURNAL · 2026 · Same journal